North Korea has developed a vaccine against coronavirus and has already begun clinical trials. About it reports RIA Novosti with reference to the portal about the scientific achievements of North Korea.
It is reported that a vaccine refers to the type of recombinant subunit, that is, aimed only to cause the body’s immune response. The advantage of these drugs is their safety. Lack of vaccines of this type is that they require regular vaccinations, since they have very low immunogenicity, the fact is that they are disposable.
Clinical trials of the drug began in July, the vaccine has shown its effectiveness and safety on animals, however scientists are faced with the complexities of human trials because the country has not registered any SARS CoV infected-2.
Earlier it was reported that registration of a Russian vaccine against the coronavirus is expected in August. Phase II trials of the Russian vaccine, developed by the Institute Gamalei, will end on 3 August, the third will take place including abroad. Production, probably deployed in Saudi Arabia.
